Cefazolin

A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.

A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.

Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.

• Bacterial Septicemia caused by susceptible Bacterial Infections
• Biliary tract infection bacterial caused by susceptible Bacterial Infections
• Bone and Joint Infections caused by susceptible Bacterial Infections
• Catheter-related Bloodstream Infection (CRBSI) NOS
• Community Acquired Pneumonia (CAP)
• Endocarditis caused by susceptible Bacterial Infections
• Genital infection caused by susceptible Bacterial Infections
• Osteoarticular Infections
• Postoperative Infections
• Respiratory Tract Infection Bacterial caused by susceptible Bacterial Infections
• Skin and Soft Tissue Infections (SSTIs)
• Skin and Subcutaneous Tissue Infection caused by susceptible Bacterial Infections
• Susceptible infections
• Urinary Tract Infection caused by susceptible Bacterial Infections
• Perioperative infection
• Susceptible Bacterial Infections